GlobalData
GlobalData

Irene Robinson

  • Home
  • Author: Irene Robinson

LabCorp’s at-home COVID-19 test to reduce demand for PPE

Following the Food and Drug Administration’s (FDA) authorization of the first COVID-19 diagnostic test with a home-collection option; Aliyah Farouk, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “GlobalData expects LabCorp’s at-home COVID-19 test to ease demand for much needed personal protective equipment (PPE). Although the test can currently […]
Read more

Healthcare sector witnesses rebound in deal activity during the week ended 19 April, 2020

The number of deals announced in the global healthcare sector (including pharmaceuticals and medical equipment) grew by 19% during the week ended 19 April, 2020, compared to the previous week, according to GlobalData’s deals database. Aurojyoti Bose, Analyst at GlobalData, comments: “Deal activity has remained inconsistent since the COVID-19 outbreak. However, the healthcare sector has […]
Read more

KidneyIntelX™ to assess risk of adverse kidney events in COVID-19 patients

Following the announcement that Renalytix AI’s KidneyIntelX™ platform will be used to assess the risk of kidney injury in COVID-19 patients; Azadeh Laffafian, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “There are multiple reports of acute kidney injury in hospitalized COVID-19 patients. Additionally, patients with prior kidney disease are […]
Read more

Recovered patient antibody treatments against COVID-19 underway

With the continuation of the COVID-19 pandemic and possible vaccines approximately one year away from launch, the race to find a treatment for the disease continues. A growing number of pharmaceutical companies have begun work on recovered patients’ antibody treatments for COVID-19. As monoclonal antibody (mAb) drugs are some of the top sellers in the […]
Read more

COVID-19 pandemic interferes with treatments in female health space

The American Society of Reproductive Medicine (ASRM) issued guidance on fertility treatments during COVID-19 and called for suspension of most new treatment cycles such as IVF. Furthermore, The European Society of Human Reproduction and Embryology (ESHRE) has advised women not to undergo IVF treatment during the pandemic. This may impact the demand and 2Q sales […]
Read more
1 13 14 15